Human anaplasmosis and Anaplasma ovis variant.
Dimosthenis
D
Chochlakis
Ioannis
I
Ioannou
Yannis
Y
Tselentis
Anna
A
Psaroulaki
D000328:Adult; D042323:Anaplasma ovis / Q000235:genetics / Q000302:isolation & purification*; D000712:Anaplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000907:Antibodies, Bacterial / Q000032:analysis; D001733:Bites and Stings; D002443:Ceftriaxone / Q000008:administration & dosage; D015377:Cilastatin / Q000008:administration & dosage; D000077728:Cilastatin, Imipenem Drug Combination; D003535:Cyprus; D004269:DNA, Bacterial / Q000032:analysis / Q000235:genetics; D004318:Doxycycline / Q000008:administration & dosage; D004338:Drug Combinations; D005260:Female; D005334:Fever / Q000188:drug therapy; D005798:Genes, Bacterial; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage; D010802:Phylogeny; D013987:Ticks
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D002443:Ceftriaxone; D000077728:Cilastatin, Imipenem Drug Combination; D004318:Doxycycline